| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90bdd3287688eb3c00e3b10a6877fb97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2008-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db23003ebdccc910c99438dc3dff3a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae01116f0dfac48348dbc439485f072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48dfb8de06f764744bfac1aa78204e21 |
| publicationDate |
2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2527466-A2 |
| titleOfInvention |
Genetic variants on CHR2 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
| abstract |
The invention pertains to certain genetic variants on Chr2q35 and as susceptibility variants of breast cancer. Methods of risk assessment and diagnosis of increased and/or decreased susceptibility to breast cancer, using such variants are described. The invention further relates to kits for diagnosing a susceptibility to breast cancer. |
| priorityDate |
2007-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |